Home›Companies›Biotech & Pharma›Amend Surgical

Amend Surgical, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 25, 2024·Suggest an edit

About Amend Surgical

Amend Surgical is a private company based in Gainesville, Florida. It has reported $2,270,760 raised in five offerings on Form D since April 2016. Its chief executive is Robert Lane.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 11, 2024Jun 25, 2024$1,049,473of $3.5M target5$209KEquityRule 506(b)Form D ↗
Apr 22, 2022May 5, 2022$371,287of $500K target9$41,254EquityRule 506(b)Form D ↗
Feb 1, 2017Apr 5, 2017$200,000fully sold3$66,667Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Sep 30, 2015Apr 15, 2016$650,000of $1.1M target4$162KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Dec 7, 2015Dec 21, 2015$0target not set1$0EquityRule 506(b)Form D ↗
Total, five offerings$2,270,760

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Amend Surgical's Form D filed Jun 25, 2024.

RC
Ronald Cobb
Director
JK
James Kirk
Director
WP
Wade Pilling
Director
MO
RL
Robert Lane
President and CEO, director

Earlier filings also listed Leslie Molony (director, last listed Apr 2017), Gary Ascani (director, last listed Apr 2016) and Jane Molony (secretary and director, last listed Dec 2015).

Sources

  1. SECAmend Surgical, Inc. filing history